Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03718338 · ClinicalTrials.gov registry record
Mechanisms of Metabolic and Hormone Action on Plaque Formation in Brain and Carotid Vessels in Patients With Prostate Adenocarcinoma
A clinical trial, sponsored by University of Washington.
- Terminated
- Registry status
- 2
- Enrollment target
NCT03718338: Clinical Trial study, sponsored by University of Washington.
NCT03718338 is a clinical trial that was terminated before completion, run by University of Washington. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03718338 was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This trial studies the mechanisms of metabolic and hormone action on plaque formation in brain and carotid vessels in patients with prostate adenocarcinoma. Studying the biomarkers in the laboratory may help doctors know the impact of androgen deprivation on metabolic, brain and cardiovascular endpoints.
Primary Outcome
Change From Baseline visual characterization scan results at 12 months
Interventions
- OTHER Quality-of-Life Assessment
- PROCEDURE Evaluation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-10-08 |
| Est. Completion | 2020-03-12 |
Why NCT03718338 stopped before completion
NCT03718338 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.
NCT03718338 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03718338 about?
NCT03718338 is a clinical study titled "Mechanisms of Metabolic and Hormone Action on Plaque Formation in Brain and Carotid Vessels in Patients With Prostate Adenocarcinoma". This trial studies the mechanisms of metabolic and hormone action on plaque formation in brain and carotid vessels in patients with prostate adenocarcinoma. Studying the biomarkers in the laboratory may help doctors know the impact of androgen deprivation on metabolic, brain and cardiovascular endpo...
What is the current status of trial NCT03718338?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2019-10-08. Estimated completion is 2020-03-12.
What interventions are being tested in trial NCT03718338?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Evaluation (PROCEDURE).
Who is sponsoring clinical trial NCT03718338?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI